First-in-human experience with Aortix intraaortic pump.

ABSTRACT:

Background

There are limited options for percutaneous mechanical circulatory support (pMCS) in patients requiring high-risk percutaneous coronary intervention.

Objectives

This first-in-human, single-center study aimed to evaluate the safety and feasibility of a novel pMCS device in high-risk percutaneous coronary intervention patients.

Methods

Aortix (Procyrion, Houston, Texas) is a pMCS device deployed in the descending aorta via the femoral artery that uses axial flow to provide cardiac unloading and augment renal and systemic perfusion. We assessed the use and effect of the Aortix device in six patients undergoing high-risk PCI. All patients had impaired left ventricular function, complex coronary disease, renal dysfunction, and suitable iliofemoral anatomy for Aor

SUBMITTER: Vora AN 

PROVIDER: S-EPMC6586004 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature